When to Increase Paroxetine ER Dose
Increase paroxetine ER dose after 1 week if inadequate symptom control is achieved, with subsequent dose adjustments made at intervals of at least 1 week, titrating in 10-mg increments up to a maximum of 50 mg/day for depression or 60 mg/day for anxiety disorders.
Initial Dosing and Assessment Period
Start paroxetine at 20 mg once daily for major depressive disorder, social anxiety disorder, and generalized anxiety disorder 1. For panic disorder, begin at 10 mg daily 1. The initial dose serves as both the starting point and, for many patients, the therapeutic dose.
Assess response after 1 week of treatment. If patients show inadequate symptom control or desire greater symptom relief, proceed with dose escalation 1.
Dose Escalation Strategy
Timing of Increases
- Minimum interval: 1 week between dose adjustments for shorter half-life SSRIs like paroxetine 2
- This weekly interval allows adequate time to assess tolerability and therapeutic response
- More conservative approaches using 1-2 week intervals are appropriate for mild-to-moderate presentations 2
Incremental Dosing
- Increase by 10 mg at each adjustment 1, 3
- Continue titration until optimal benefit-to-harm ratio is achieved
- Maximum doses: 50 mg/day for depression 1, 60 mg/day for OCD and panic disorder 1
Special Populations Requiring Slower Titration
Elderly patients (>60 years): Consider starting at lower doses (potentially 2.5 mg/day) and increasing by 2.5 mg every other day 4. This slow titration approach in older adults with high anxiety or GAD comorbidity resulted in 84% remission rates versus 54.5% with standard titration, with dramatically lower dropout rates (20% vs 77.3%) 4.
Panic disorder patients: May benefit from very gradual titration due to sensitivity to SSRI stimulating effects 5. While standard weekly 10-mg increases are generally effective, some patients experience fewer early panic symptoms with slower titration 5.
Clinical Decision Points for Dose Increase
When to Increase
- Inadequate response after 1-3 weeks at current dose 3
- Confirmed medication adherence
- Tolerable side effects at current dose
- Target symptoms persist (assess using standardized rating scales) 2
When NOT to Increase
- Adequate symptom control achieved - most patients respond to 20 mg/day 1, 3
- Dose-limiting adverse effects present
- Maximum recommended dose reached
- Poor medication adherence (address this first)
Important Caveats
Higher doses do not necessarily equal better outcomes. Evidence suggests the relationship between dose and response magnitude is unclear, while higher doses consistently associate with more adverse effects 2. The 2020 AACAP guidelines specifically note this concern.
Monitor for specific adverse effects with dose increases:
- Nausea (significantly increased at 20 mg paroxetine vs lower doses) 6
- Sexual dysfunction
- Discontinuation syndrome risk (paroxetine has high risk) 2
- Serotonin syndrome when combined with other serotonergic agents 2
Therapeutic drug monitoring may optimize dosing. Recent evidence suggests plasma concentrations of 65-120 ng/mL predict optimal response with fewer adverse effects 7. Concentrations above 120 ng/mL associate with increased liver injury and weight gain without additional benefit 7.
CYP2D6 poor metabolizers require special consideration - they achieve substantially higher drug levels (up to 7-fold AUC increase) and face increased toxicity risk 8. Consider genetic testing in patients with unexpected adverse effects or treatment resistance.
Practical Algorithm
- Week 0: Start 20 mg daily (10 mg for panic disorder)
- Week 1: Assess response and tolerability
- If inadequate response + good tolerability → increase to 30 mg
- If adequate response → continue current dose
- If poor tolerability → address side effects, consider slower titration
- Week 2+: Repeat assessment weekly
- Continue 10-mg increases at weekly intervals until remission or maximum dose
- For elderly/anxious patients: consider 2.5-mg increases every 2 days
- Weeks 4-6: Full therapeutic effect expected 1
- If no response at adequate dose/duration → consider alternative strategies
The goal is remission, not just response - continue titration until symptoms fully resolve or dose-limiting effects occur 2.